Announced Mon, 22 Jun · 15:58 IST
CARE Ratings assigns A+ Stable issuer rating to IKS Health
IKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.7%1-day move
₹1691.10
prior close
₹1695.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.2-0.0+1.5+1.7+0.6+0.5-0.7+6.7+10.0+11.1+6.4——
Up moveDown movePending
AI summary
CARE Ratings assigned IKS Health a new issuer rating of CARE A+ with Stable outlook. Backed by strong US healthcare outsourcing presence, integrated platform, and FY26 revenue of Rs 3,194 crore (up 20%), PAT Rs 722 crore. Company is debt-funding the USD 560 million (about Rs 5,320 crore) TruBridge acquisition, which may raise leverage. FY26 gearing improved to 0.27x.
Likely market impact
New A+ Stable rating signals strong creditworthiness despite upcoming debt for TruBridge acquisition. Reassuring for shareholders.